Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register...
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR’s Comprehensive Approach to RNA-targeted Technologies
SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing, and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, today announced that they have entered into...
SUMMIT HEALTHCARE ACQUISITION CORP. AND YS BIOPHARMA ANNOUNCE EFFECTIVENESS OF REGISTRATION STATEMENT AND EXTRAORDINARY GENERAL MEETING DATE FOR PROPOSED BUSINESS COMBINATION
Extraordinary general meeting of Summit Healthcare Acquisition Corp.'s shareholders to be held on March 1, 2023 at 9:00 a.m. Eastern Time YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer YS Biopharma achieved...
Lunit and Agfa HealthCare bring breast imaging AI solution to Dubai Academic Health Corporation (DAHC) Dubai Hospital
Dubai Academic Health Corporation (DAHC) Dubai Hospital to modernize its Breast Cancer Diagnostic and Screening program with Agfa HealthCare's RUBEE for AI framework and Lunit INSIGHT MMG algorithm The Breast AI Analysis Package is Lunit's first application with Agfa HealthCare since forming a strategic partnership in 2021 SEOUL, South Korea,...
Armis Scores as a Top Performer in the 2023 Best in KLAS Software & Services Report
Asset Visibility and Security Company Rated a High Scorer, Showcasing Leading Healthcare Prowess SAN FRANCISCO, Feb. 8, 2023 /PRNewswire/ -- Armis, the leading asset visibility and security company, today announced that it has been named a top performer by KLAS Research in the 2023 Best in KLAS Software & Services Report for Healthcare IoT...
Waterdrop internally tests a ChatGPT-like application and will apply It into insurance marketing and services
BEIJING, Feb. 8, 2023 /PRNewswire/ -- In a media interview, Huang Mingxing, who heads Waterdrop's AI business, said Waterdrop has internally tested a ChatGPT like application, and will apply it to insurance marketing and services. As an AI-enabled chatbot application developed by Open AI, ChatGPT can chat with users and even write emails, do copy writing or translation and...
Meihua International Medical Technologies Co. Explores Application of ChatGPT Technologies to Develop Online AI Health Consultation Services
YANGZHOU, China, Feb. 8, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today announced the Company will seek to explore the application of ChatGPT technologies to develop online health consultation services and...
Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience
SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the application of ChatGPT (Chat Generative Pre-trained Transformer) for content creation and patient interactions to enhance the capabilities in delivering quality experience of patient management services. ChatGPT...
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center
The additional investment for the 'R&PD Center' was confirmed by the board of directors committee with a total of 261 million USD SK bioscience plans to establish a vaccine-biopharmaceutical hub, organizing a global cooperative model against new pandemics SEONGNAM, South Korea, Feb. 8, 2023 /PRNewswire/ -- SK bioscience, a global...
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc.
SHANGHAI, Feb. 8, 2023 /PRNewswire/ -- Shanghai MicuRx Pharmaceutical Co., Ltd. ("MicuRx," 688373) announced recently that it has appointed Regis A. Vilchez, MD, PhD, an experienced R&D biopharmaceutical executive and infectious disease expert, as Chief Medical Officer of its American subsidiary, MicuRx Pharmaceuticals, Inc. He oversees new drug development programs and clinical activities in the United States, Europe and...
